Ensysce Biosciences, Inc.
ENSC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001716947
In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Ensysce Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −5 vs. Q3 2022
- Shares held
- 184.8K
- −4.40K (−2.3%) vs. Q3 2022Converted for a 1-for-20 split
- Total value
- $138.2K
- −$672.5K (−83.0%) vs. Q3 2022
- New holders
- 7
- 3 more added
- Sold out
- 12
- 2 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $261.1K |
| Q1 2026 | 15 | $261.5K |
| Q4 2025 | 17 | $461.1K |
| Q3 2025 | 17 | $833.7K |
| Q2 2025 | 11 | $398.8K |
| Q1 2025 | 9 | $903.4K |
| Q4 2024 | 8 | $1.15M |
| Q3 2024 | 13 | $580.5K |
| Q2 2024 | 11 | $253.0K |
| Q1 2024 | 10 | $236.5K |
| Q4 2023 | 9 | $56.4K |
| Q3 2023 | 12 | $231.1K |
| Q2 2023 | 9 | $714.0K |
| Q1 2023 | 10 | $103.2K |
| Q4 2022 | 14 | $138.2K |
| Q3 2022 | 20 | $810.7K |
| Q2 2022 | 21 | $3.41M |
| Q1 2022 | 21 | $6.23M |
| Q4 2021 | 18 | $15.9M |
| Q3 2021 | 16 | $9.56M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Ensysce Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 8 | $6 | 0.00% | +0+6.0% | AddedConverted for a 1-for-20 split |
| Wolverine Asset Management LLC | 150 | $112 | 0.00% | −99−39.8% | ReducedConverted for a 1-for-20 split |
| Plante Moran Financial Advisors, LLC | 248 | $186 | 0.00% | +248 | New |
| Morgan Stanley | 276 | $207 | 0.00% | +276+183,900.0% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 760 | $1.00K | 0.00% | −12−1.5% | ReducedConverted for a 1-for-20 split |
| Bank of America Corp | 6,051 | $4.54K | 0.00% | +6,051 | New |
| Stifel Financial Corp | 10,832 | $8.12K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock Inc. | 11,712 | $8.78K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| UBS Group AG | 13,884 | $10.4K | 0.00% | +11,277+432.5% | AddedConverted for a 1-for-20 split |
| Millennium Management LLC | 14,438 | $11.0K | 0.00% | +14,438 | New |
| Susquehanna International Group, LLP | 17,649 | $13.2K | 0.00% | +17,649 | New |
| Acadian Asset Management LLC | 26,602 | $19.0K | 0.00% | +26,602 | New |
| Two Sigma Investments, LP | 39,870 | $29.9K | 0.00% | +39,870 | New |
| Citadel Advisors LLC | 42,277 | $31.7K | 0.00% | +42,277 | New |
| HG Vora Capital Management, LLC | 0 | $0 | 0.00% | −123,125−100.0% | Sold outConverted for a 1-for-20 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −15,791−100.0% | Sold outConverted for a 1-for-20 split |
| Cerity Partners LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold outConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −6,526−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,554−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,089−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −1,778−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,700−100.0% | Sold outConverted for a 1-for-20 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −1,022−100.0% | Sold outConverted for a 1-for-20 split |
| StoneX Group Inc. | 0 | $0 | 0.00% | −639−100.0% | Sold outConverted for a 1-for-20 split |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-20 split |
| Moneta Group Investment Advisors LLC | 0 | $0 | 0.00% | −256−100.0% | Sold outConverted for a 1-for-20 split |
| Covington Capital Management | – | – | – | – | Not filed |